Molecular aspects of sand-fly-based vaccine development

dc.contributor.authorVieira Coutinho Abreu Gomes, Iliano
dc.date.accessioned2011-06-07T17:38:19Z
dc.date.available2011-06-07T17:38:19Z
dc.date.graduationmonthAugusten_US
dc.date.issued2011-06-07
dc.date.published2011en_US
dc.description.abstractThe emergence and reemergence of vector-borne diseases pose significant threats to humans and other animals worldwide. Although vector control relies mostly on insecticides, the emergence of insecticide resistance urges for the development of new strategies to control the spread of such diseases. For sand fly-transmitted leishmaniasis, Transmission Blocking Vaccines (TBV) may constitute a feasible strategy to impair Leishmania transmission from infected to uninfected vertebrate hosts. Moreover, sand fly saliva-based vaccines represent an alternative or complementary approach as these vaccines protect different mammalian hosts against Leishmania. Based on the potential use of sand fly molecules as vaccines against leishmaniasis, we assessed the potential of Phlebotomus papatasi midgut secreted proteins as TBV candidates and the expression variability of sand fly salivary gland genes. Regarding the TBV approach, we took advantage of the RNA interference (RNAi) technique to evaluate the effects of knocking down P. papatasi midgut-specific genes on Leishmania major development within the sand fly midgut. Whereas peritrophin 1 (PpPer1) knock down led to increased Le. major load by 39%, knocking down chitinase 1 (PpChit1) reduced Le. major load in P. papatasi midguts by 63%. Thus, our data strongly suggest that PpChit1 constitutes a potential target for TBV approaches against Leishmania transmission in endemic areas. Concerning protective vaccines based on salivary gland secreted proteins, we searched for expression polymorphism in selected salivary gland genes in natural and colonized populations of P. papatasi. Significant differences in salivary gland gene expression were not only exhibited in P. papatasi specimens collected in different geographic habitats but also seasonal difference in gene expression was displayed by specimens belonging to the same population. As antigen dose is an important component of immune responses, different doses of salivary protein inoculated into host skin may interfere with vaccine protection. Thus, the efficacy of sand fly saliva-based vaccine upon exposure to different salivary protein doses must be evaluated before deployment in endemic areas. Our data also ruled out some biotic factors as responsible for fine-tuning the expression of such genes. Overall, this dissertation makes significant contribution to the development of sand fly-based vaccines against leishmaniasis.en_US
dc.description.advisorMarcelo Ramalho-Ortigaoen_US
dc.description.degreeDoctor of Philosophyen_US
dc.description.departmentDepartment of Entomologyen_US
dc.description.levelDoctoralen_US
dc.description.sponsorshipNIHen_US
dc.identifier.urihttp://hdl.handle.net/2097/9224
dc.language.isoen_USen_US
dc.publisherKansas State Universityen
dc.subjectSand fliesen_US
dc.subjectPhlebotomus papatasien_US
dc.subjectVaccineen_US
dc.subjectPeritrophic matrixen_US
dc.subjectSalivary glanden_US
dc.subjectGene expressionen_US
dc.subject.umiEntomology (0353)en_US
dc.titleMolecular aspects of sand-fly-based vaccine developmenten_US
dc.typeDissertationen_US

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
IlianoGomes2011.pdf
Size:
3.18 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.61 KB
Format:
Item-specific license agreed upon to submission
Description: